Observation of supplementary treatment effect of spirin and transfer factor for treating reteated pulmonary tuberculosis
He Lianfu, Cha Jianyuan,Wu Shilin. Affiliated Hospital of DaLi Medical college,DaLi, 671000, China
Objective To observe the supplementary treatment effect for pulmonary tuberculosis treated of spirin and transfer factor.Methods One hundred and ninety two patients were divided into two groups: therapy group with 100 cases, control group with 92 cases. The therapy group received chemical therapy and three spirin capsules, three times a day, transfer factor 3mg, imjection(H) twice a week.Results At the end of 9 months, the sputum conversion rate was 92%(in therapy group), 73.9%(in control group), P0.01. The foci absorption was 88%(therapy group) and 76%(control group), Cavity cloce up was 73.9% (ther-apy group), 59.8%(control group),P0.05. The therapy group's side effect rate (6%) was lower than that of control group(26%), P0.01. Conclusion The supplementary treatment effect of spirin and transfer factor for treating retreated pulmonary tuberculosis was obvious. Especially for reducing side effect of antituberculosis.
【CateGory Index】： R521